Stocks in Action: Schott Pharma, Fresenius, Vonovia, Hannover Rück, Bechtle
Reading Time: 4 minutes
Stock 1.) Schott Pharma - Hype surrounding Wegovy & Co creates momentum, Barclays upgrades to Overweight with a price target of €32 (price potential: 18%)! One of the most important buy ratings comes on Tuesday from Barclays analysts for Schott Pharma. The pharmaceutical packaging manufacturer is currently one of the leading producers of pen injection systems for GLP-1 drugs, benefiting from the hype surrounding diabetes and obesity medications such as Wegovy. Recently, the company surprised with a very strong Q2 result, with adjusted operating...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
